EDGEMOND JAMES sold UTHR
May 7, 2026 · Form 4 insider transaction
EDGEMOND JAMES sold 160 shares of United Therapeutics Corporation at $597.54 per share, a transaction worth $95.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
160
Price
$597.54
Total value
$95.6K
InsiderEDGEMOND JAMES
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 7, 2026
Filing dateMay 11, 2026
Shares owned after18,876
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025.